Application Note: Analysis of extractable and leachable metals in plastic materials of construction as per USP <661.1>
Posted: 14 December 2017 | Agilent Technologies | No comments yet
Plastic packaging systems for pharmaceutical use include, but are not limited to bags, bottles, vials, ampoules, cartridges, dry powder and metered dose inhalers, syringes, blisters, pouches and their associated closures and secondary components like labels and printing overpouches…
Plastic materials that are commonly used in packaging systems include polyethylene, polypropylene, cyclic olefins, polyethylene terephthalate, polyethylene terephthalate G, and plasticized polyvinyl chloride, among others.
Drug products can chemically interact with their associated packaging systems and/ or the system’s plastic materials and components of construction while the product is being manufactured, shipped, stored and administered.
As per USP <661.1> the magnitude of these interactions must not be such that the interactions adversely affect the suitability for use of the drug product or the packaging system.
Complete the form below to download the full Application Note:
Related content from this organisation
- Raman spectroscopy market expected to value $875m by 2028
- HPLC market projected to value $8 million by 2030
- ebook: Nanoparticle formulations: overcoming dissolution challenges
- Application note: Rapid identification of Polysorbates 20 and 80 through amber bottles
- Biopharmaceutical bioseparation systems market to value $20bn
Related topics
Data Analysis, Drug Development, Drug Safety, Manufacturing, Packaging, QA/QC, Research & Development (R&D), Technology
